✦ LIBER ✦
Phase I/II Multicenter Clinical Trial of Lenalidomide Maintenance After Allogeneic Hematopoietic Cell Transplant (alloHCT) in Patients with High Risk (HR) Multiple Myeloma (MM)
✍ Scribed by Becker, Pamela S.; Alsina, Melissa; Zhong, Xiaobo; Hari, Parameswaran N.; Rowley, Scott; Stadtmauer, Edward A.; Vesole, David; Logan, Brent R.; Weisdorf, Daniel J.; Qazilbash, Muzaffar; Popplewell, Leslie; Navarro, Willis H.; Tomblyn, Marcie; Giralt, Sergio A.; Pasquini, Marcelo C.
- Book ID
- 123275944
- Publisher
- Elsevier Science
- Year
- 2013
- Tongue
- English
- Weight
- 60 KB
- Volume
- 19
- Category
- Article
- ISSN
- 1083-8791
No coin nor oath required. For personal study only.